Review Oncologic, Endocrine & Metabolic: Inhibitors of protein farnesylation: A new approach to cancer chemotherapy
- 1 December 1995
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 5 (12), 1269-1285
- https://doi.org/10.1517/13543776.5.12.1269
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Cylindrol A: A Novel Inhibitor of Ras Farnesyl-Protein Transferase from Cylindrocarpon lucidumTetrahedron Letters, 1995
- Stereochemistry of the benzodiazepine based Ras farnesyltransferase inhibitorsBioorganic & Medicinal Chemistry Letters, 1995
- Actinoplanic Acid A: A Macrocyclic Polycarboxylic Acid Which Is a Potent Inhibitor of Ras Farnesyl-Protein TransferaseJournal of the American Chemical Society, 1994
- Rational design of potent carboxylic acid based bisubstrate inhibitors of ras farnesyl protein transferaseBioorganic & Medicinal Chemistry Letters, 1994
- Phenol based tripeptide inhibitors of ras farnesyl protein transferaseBioorganic & Medicinal Chemistry Letters, 1994
- Raf meets Ras: completing the framework of a signal transduction pathwayTrends in Biochemical Sciences, 1994
- Peptide based P21RAS farnesyl transferase inhibitors: systematic modification of the tetrapeptide CA1A2X motifBioorganic & Medicinal Chemistry Letters, 1994
- Zaragozic Acids D and D2: Potent Inhibitors of Squalene Synthase and of Ras Farnesyl-Protein TransferaseJournal of Natural Products, 1993
- Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal CellsScience, 1993
- Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase InhibitorScience, 1993